The decision making process that underlies ovarian hormone therapy (HT) is fallible.
Two recent large-scale studies, one in the USA (Women s Health Initiative or WHI) and the other in Great Britain, cast a negative light on the use of hormone therapy. Both have received considerable attention in the media. Thus, the decision for women to go on hormone therapy (HT) remains controversial. There is an historical oscillation of beliefs related in part to expectations of the medicinal value of HT over longer-term use beyond the initial peri-menopausal period. Studies thought to resolve issues surrounding the efficacy of HT were perhaps over-stated. Confusion still permeates the decision making with regard to HT. Over zealous advertising, and exaggerated understanding of the results (negative or positive) undermines patient and physician decision making.
Hormone Therapy: Biological, Social, and Medical Context.- Demythologized Human Decision-Making.- Autonomic Regulation, Heart, and Strokes.- Bad News-Good News: Cancers and Bone.- Brain, Mood, and Cognition.- Physicians' and Women's Responses to HT Findings: Implications for Continuous Learning and Self-Corrective Inquiry for Physicians.
The decision making process that underlies ovarian hormone therapy (HT) is fallible. Thus, the decision for women to go on HT remains controversial. At a time when confusion still permeates the decision making with regard to HT, this book bridges diverse features that surround the decision making concerning HT. The book is written for both specialists and generalists in the field.
Written for both specialists and generalists in the field
Bridges diverse features that surround the decision-making concerning hormone therapy